Exscientia plc (EXAI)
Market Cap | 545.02M |
Revenue (ttm) | 25.42M |
Net Income (ttm) | -184.76M |
Shares Out | 125.70M |
EPS (ttm) | -1.47 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 62,356 |
Open | 4.400 |
Previous Close | 4.380 |
Day's Range | 4.295 - 4.400 |
52-Week Range | 4.140 - 9.120 |
Beta | 0.78 |
Analysts | Buy |
Price Target | 9.75 (+124.14%) |
Earnings Date | May 22, 2024 |
About EXAI
Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs. The company's lead product candidate GTAEXS617, a CDK7 inhibitor, which is currently in a Phase 1/2 trial to manage the potential toxicities associated with CDK7 as well as optimizing pharmacokinetics for maximizing on-target efficacy. It is also involved in the development of EXS4318, a PKC-theta inhibitor, under Phase 1 clinical trial for inflammation and immunology indi... [Read more]
Financial Performance
In 2023, Exscientia's revenue was 20.08 million, a decrease of -26.24% compared to the previous year's 27.22 million. Losses were -145.96 million, 22.9% more than in 2022.
Financial numbers in GBP Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for EXAI stock is "Buy." The 12-month stock price forecast is $9.75, which is an increase of 124.14% from the latest price.
News
Investors who lost money on Exscientia plc should contact Levi & Korsinsky about an ongoing investigation - EXAI
NEW YORK, NY / ACCESSWIRE / March 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violation...
Levi & Korsinsky Reminds Exscientia plc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - EXAI
NEW YORK, NY / ACCESSWIRE / March 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violation...
EXAI ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Exscientia plc
NEW YORK, NY / ACCESSWIRE / March 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violation...
Lost Money on Exscientia plc(EXAI)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / March 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violation...
Exscientia Business and Financial Update for the Full Year 2023
OXFORD, U.K.--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) Recent advancements in the Company's pipeline, collaborations and operations, as well as financial results for the fourth quarter and full ...
An Investigation Has Commenced on Behalf of Exscientia plc Shareholders. Contact Levi & Korsinsky to Discuss your EXAI Losses.
NEW YORK, NY / ACCESSWIRE / March 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violation...
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended December 31, 2023, on Thursday, March 21, 2024, before the open...
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Exscientia plc (EXAI)
NEW YORK, NY / ACCESSWIRE / March 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violation...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Exscientia plc - EXAI
NEW YORK,, March 11, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Exscientia plc ("Exscientia" or the "Company") (NASDAQ: EXAI). Such investors are advised to ...
Levi & Korsinsky, LLP Investigates Possible Securities Fraud Violations by Exscientia plc (EXAI)
NEW YORK, NY / ACCESSWIRE / March 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violations...
EXAI STOCK ALERT: Levi & Korsinsky Notifies Exscientia plc Investors of an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violations...
Levi & Korsinsky Reminds Shareholders of an Investigation into Exscientia plc (EXAI) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violations...
EXAI ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Exscientia plc
NEW YORK, NY / ACCESSWIRE / March 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violations...
Levi & Korsinsky Announces an Investigation on Behalf of Exscientia plc (EXAI) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / March 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violations...
Exscientia plc (EXAI) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / March 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violations...
Did Exscientia plc Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - EXAI
NEW YORK, NY / ACCESSWIRE / March 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exscientia plc ("Exscientia plc") (NASDAQ:EXAI) concerning possible violations...
Exscientia to Present at Upcoming Investor Conferences in March
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced that members of management will participate in the following upcoming investor conferences in March: TD Cowen 44th Annua...
Exscientia plc (EXAI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)---- $EXAI #classaction--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exscientia plc (“Exscientia” or “the Company”) (NASDAQ...
Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced the initiation of EXCYTE-2, an observational clinical study in acute myeloid leukaemia (AML) to investigate the relation...
Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)
OXFORD, England--(BUSINESS WIRE)--Professor Andrew Hopkins FRS FMedSci, founder and Chief Executive of Exscientia plc (Nasdaq: EXAI), has been appointed Commander of the Order of the British Empire (C...
Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced that Sanofi is adding a new discovery stage programme identified and initially advanced by Exscientia into the current c...
Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) announced today that the Company received a $2.3 million grant from Open Philanthropy, a philanthropic funder with several programs in g...
Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conf...
Exscientia Business Update for Third Quarter 2023
OXFORD, U.K.--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI): Recent advancements in the Company's pipeline, collaborations and operations, as well as financial results for the third quarter of 2023, ...
Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, before the open of U.S. mar...